期刊文献+

2型糖尿病患者胰岛β细胞分泌功能分级及其临床意义 被引量:6

Functional classification criteria for β cell insulin secretion in the patients with type 2 diabetes, and its clinical significance
暂未订购
导出
摘要 目的探讨2型糖尿病(T2DM)患者胰岛β细胞分泌功能分级标准,对T2DM诊治提供科学依据。方法选择T2DM患者219例,对空腹血糖(FPG)、糖化血红蛋白(HbAlc)、胰岛素的峰值(P INS)及与基础值的比值(Ip/Io)、C-肽峰值(Pc-p)及与基础值的比值(Cp/Co)等指标进行整理分析,拟定T2DM患者胰岛β细胞分泌功能分级标准。结果依据P INS、Ip/Io、Pc-p及Cp/Co等多项指标,T2DM患者胰岛β细胞分泌功能可分为三级:Ⅰ级(轻度异常)、Ⅱ级(中度异常)、Ⅲ级(重度异常)。结论胰岛β细胞分泌功能分级对指导T2DM患者临床诊治具有重要的理论意义和实际应用价值。 Objective To investigate functional classification criteria for 13 cell insulin secretion in the patients with type 2 diabetes (T2DM) so as to provide scientific basis for the diagnosis and treatment of T2DM. Methods From October 2009 to July 2012, 219 inpatients with T2DM in author's hospital were enrolled in this study. According to indicators of fasting blood glucose, HbAlc, the insulin peak and the ratio (it/the fasting insulin) i.e Ip/Io, the C-peptide peak and the ratio (it/the fasting C-peptide) i.e Cp/Co, authors tried to quantify functional classification for 13 cell insulin secretion in the patients with T2DM. Results The functional classification criteria for 13 cell insulin secretion could be as follows: class I (mildly impaired), class 11 (moderately impaired), class HI (severely impaired). Conclusion To make a diagnosis and give treatment to T2DM based on the functional classification criteria for 13 cell insulin secretion has important theoretical significance and practical application value.
机构地区 [
出处 《实用医药杂志》 2013年第10期869-872,共4页 Practical Journal of Medicine & Pharmacy
关键词 2型糖尿病 胰岛Β细胞 分泌功能 分级标准 Type 2 diabetes β cell Insulin secretion Functional classification criteria
  • 相关文献

参考文献5

  • 1中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国医学前沿杂志(电子版),2011,6(3):54109.
  • 2Inzucchi SE,Bergenstal RM,Buse JB,et al.Management of hyperglycemia in type 2 diabetes:a patient-centered approach.Position statement of the American Diabetes Association(ADA)and the European Association for the Study of Diabetes(EASD)[J].Diabetes Care,2012,35(12):1364-1379.
  • 3Weng JP,Li Y,Xu W,et al.Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes:a multicentre randomized parallelgroup trial[J].Lancet,2008,371 (7):1753-1760.
  • 4Rolla A.The pathophysiological basis for intensive insulin replacement[J].Int J Obes Relat Metab Disord,2004,28(S2):3-7.
  • 5Wajchenberg BL.β-cell failure in diabetes and preservation by clinical treatment[J].Endocrine Rev,2007,28(2):187-218.

共引文献112

同被引文献41

  • 1杨正国,王霜,杨波,贾伟,郑金亮,蔡新利,徐磊,张盈,赵金娟,刘利慧,闫新爱,李倩.2型糖尿病患者胰岛素抵抗分级及临床意义[J].实用医药杂志,2013,30(12):1057-1059. 被引量:9
  • 2李霞,周智广,亓海英,陈小燕,黄干.用空腹C肽代替胰岛素改良Homa公式评价胰岛素抵抗和胰岛β细胞功能[J].中南大学学报(医学版),2004,29(4):419-423. 被引量:222
  • 3李志强,张美春,刘亚力,徐春.盐酸吡格列酮治疗2型糖尿病伴高脂血症的疗效观察[J].华中医学杂志,2005,29(4):255-256. 被引量:7
  • 4陈灏珠.实用内科学[M]11版[M].北京:人民卫生出版社,2001.957-959.
  • 5Pan CY, Yang WY, Jia WP, et al. Management of Chinese patients with type 2 diabetes, 1998 -2006: the Diabcare- China Surveys [ J ]. Curt Med Res Opin ,2009,25 (1) :39 -45.
  • 6中华医学会糖尿病学分会.中国2型糖尿病防治指南[J].中国医学前沿杂志,2010,3(6):54-109.
  • 7Defronzo RA,Banting Lecture.From the triumvirate to the ominous octet:a new paradigm for the treatment of type 2 diabetes mellitus[J].Diabetes,2009,58(7):773-795.
  • 8中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中华内分泌代谢杂志,2011,27(2):增录12b-1-36.
  • 9Gupta D,Krueger CB,Lastra G,et al.Over-nutrition,obesity,and insulin resistance in the development ofβ-cell dysfunction[J].Curr Diabetes Res,2012,8(1):76-83.
  • 10U.K.Prospective Diabetes Study(UKPDS)Group:Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes(UKPDS 33)[J].Lancet,1998,352(8):837-853.

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部